November 14 Is World Diabetes Day

[AlaskaDenise]

World Diabetes Day was first introduced by the International Diabetes Federation (IDF) and the World Health Organization (WHO) in 1991, in response to the growing diabetes epidemic. In December 2006, The United Nations passed a Resolution on Diabetes (61/225). It made the existing World Diabetes Day an official UN Day.

The date was chosen because it marks the birthday of Frederick Banting, who is credited with the discovery of insulin in 1921. While many events take place on or around World Diabetes Day, a themed campaign runs throughout the year. The five year theme that starts in 2009 is Diabetes Education and Prevention.


Celebrated worldwide, World Diabetes Day brings together millions of people in over 191 countries to raise awareness of diabetes. Events on and around the day unite the global diabetes community to produce a powerful voice for diabetes awareness. The many activities that are organized each year include the lighting of monuments in the blue colour of the World Diabetes Day logo. Find out more at http://www.worlddiabetesday.org/en/get-involved


Across the internet, individuals and online communities mark World Diabetes Day and add their voices to the campaign. Join the cyber celebration at http://www.worlddiabetesday.org/en/a...s/social-media

Understand diabetes and take control


The World Diabetes Day campaign slogan is ?Understand Diabetes and Take Control?. The campaign aims to:

Encourage governments to implement and strengthen policies for the prevention and control of diabetes and its complications;

Disseminate tools to support national and local initiatives for the prevention and management of diabetes and its complications;

Illustrate the importance of evidence-based education in the prevention and management of diabetes and its complications;

Raise awareness of the warning signs of diabetes and promote action to encourage early diagnosis;

Raise awareness of and promote action to reduce the main modifiable risk factors for type 2 diabetes;

Raise awareness and promote action to prevent or delay the complications of diabetes.



The key messages of the campaign are:

Know the diabetes risks and know the warning signs.
Know how to respond to diabetes and who to turn to.
Know how to manage diabetes and take control.



The World Diabetes Day logo


IDF adopted the diabetes circle as the World Diabetes Day logo in 2007. It is a simple icon that can be easily adapted and used.


The significance of the symbol is overwhelmingly positive. Across cultures, the circle symbolizes life and health. The colour blue reflects the sky that unites all nations and is the colour of the flag of the United Nations. The blue circle signifies the unity of the global diabetes community in response to the diabetes epidemic.


Help bring diabetes to light!


World Diabetes Day provides an opportunity to reach out to individuals and encourage them to get involved in diabetes causes. The campaign aspires to a well-informed world where the myths that surround diabetes are dispelled and a motivated community come together to drive change.


The International Diabetes Federation calls on everyone affected by diabetes to join the World Diabetes Day campaign and help make these goals a reality. Support the campaign and help bring diabetes to light! Visit the World Diabetes Day website to see how you can join in the fun: http://www.worlddiabetesday.org


This section created and produced exclusively by the editorial staff of EverydayHealth.com. ? 2009 EverydayHealth.com; all rights reserved.
More on Diabetes Support
Finding Diabetes Support
Motivating a Loved One With Type 2 Diabetes
Healthy Meals for People With Type 2 Diabetes Complementary Therapies for Type 2 Diabetes
Return to World Diabetes Day Resource Guide

http://www.everydayhealth.com/health-report/world-diabetes-day-resource-guide/world-diabetes-day.aspx

[AlaskaDenise]

Re: November 14 Is World Diabetes Day

The relationship between glucose metabolism and influenza is partly through lung issues. This applies to prediabetic condition of insulin resistance, which is treatable by carbohydrate management and exercise.
-------------------------------------------------------------------------------------

Lung Function and Glucose Metabolism: An Analysis of Data from the Third National Health and Nutrition Examination Survey

ABSTRACT

Although people with diabetes have decreased lung function, the dose-response relation between measures of glucose control and lung function in nondiabetic people is not known. The authors used data from the Third National Health and Nutrition Examination Survey (1988?1994) to investigate the relation between glucose tolerance test response and other measures of glucose homeostasis and lung function in an adult population without a clinical diagnosis of diabetes. Plasma glucose level 2 hours after oral administration of 75 g of glucose was inversely related to forced expiratory volume in 1 second (FEV1), with a difference of ?144.7 ml (95% confidence interval: ?231.9, ?57.4) for persons in the highest quintile of postchallenge glucose compared with the lowest. Similar inverse associations with FEV1 were found for other measures of glucose autoregulation. Lung function did not appear to be related to fasting glucose level. Similar associations were seen for forced vital capacity (FVC) but not for the FEV1:FVC ratio. In the total study population, persons with previously diagnosed diabetes had an FEV1 119.1 ml (95% confidence interval: ?161.5, ?76.6) lower than persons without diabetes. This effect was greater in those with poorly controlled diabetes. These findings suggest that impaired glucose autoregulation is associated with impaired lung function.

(snipped)

DISCUSSION

We have demonstrated that in adults without a diagnosis of diabetes, impaired glucose regulation as indicated by glucose tolerance testing, higher levels of glycosylated hemoglobin, plasma insulin (a marker of insulin resistance (22)), and C-peptide (a by-product of insulin production), and an epidemiologic measure of insulin resistance are associated with impaired lung function in a dose-response manner. However, fasting plasma glucose was not associated with lung function. We have also demonstrated that persons with a clinical diagnosis of diabetes have impaired lung function, a finding that is consistent with previous work in this area (3?17). These findings were not explained by obesity or increasing age. This relation was seen throughout the nondiabetic values of these markers of glucose autoregulation, which suggests that the relation between glucose and lung function is not just an association seen in persons with overt diabetes. A similar association was also seen between glycemic markers and FVC but was not seen consistently with the FEV1:FVC ratio; this suggests that the effect is primarily an effect on lung function and does not influence the development of obstructive lung disease (as seen in chronic obstructive pulmonary disease).

(snipped to get last paragraph)


We have demonstrated that increases in the glucose response to a glucose tolerance test, glycosylated hemoglobin, serum insulin, and a marker of insulin resistance are all associated with a reduction in lung function as assessed by FEV1 (and FVC). This effect is not explained by confounding due to obesity. The observation that persons with diagnosed diabetes that is poorly controlled have worse lung function than persons with diagnosed diabetes who have good glucose control is consistent with the hypothesis that good control of diabetes is associated with preserved lung function. Further understanding of the effect of glucose regulation on the lungs would be obtained by assessing lung function in participants from a trial of intensive glucose regulation, such as the Diabetes Control and Complications Trial, where beneficial effects on diabetic nephropathy are seen 7?8 years after the end of the intervention (49). Although smoking is the main risk factor for loss of lung function, there is an urgent need to understand other factors that contribute to a reduction in lung function, as demonstrated by the 95 percent excess mortality among persons who have never smoked but have reduced lung function in comparison with those with normal lung function (50). In addition, the emergence of novel risk factors such as hyperglycemia will lead to increased understanding of the pathogenesis of worse lung function and hence new possibilities for intervention. In view of the public health importance of lung function in health and the increasing prevalence of diabetes, this is a subject that warrants further investigation.

http://aje.oxfordjournals.org/cgi/content/full/161/6/546

.

[AlaskaDenise]

Re: November 14 Is World Diabetes Day

Impaired glucose tolerance is NOT just an issue for the elderly.
-----------------------------------------------------------------------------------

Impaired Glucose Tolerance

Impaired glucose tolerance, along with impaired fasting glucose (IFG), is recognized as being a stage in the transition from normality to diabetes. Thus, individuals with IGT are at high risk of progressing to type 2 diabetes, although such progression is not inevitable, and probably over 30% of individuals with IGT will return to normal glucose tolerance over a period of several years.

The decision to include data on IGT was based on two major factors associated with its presence: it greatly increases the risk of developing diabetes 1 , and it is associated with the development of cardiovascular disease 2 3 . In addition, some of the best evidence we have on the prevention of type 2 diabetes comes from studies in people with IGT.

Prevalence

It is estimated that some 344 million people worldwide, or 7.9% in the age group 20-79, will have IGT in 2010, the vast majority of whom live in low- and middle-income countries. By 2030 the number of people with IGT is projected to increase to 472 million, or 8.4% of the adult population.

Age distribution

As with diabetes, the 40-59 age group is expected to have the greatest number of people with IGT with 138 million for 2010, and this will remain true in 2030 with 186 million as shown in Figure 2.3. It is also of note that nearly one-third of all those who will have IGT for 2010 are in the 20-39 age group (see Figure 2.3).

The prevalence of IGT is generally similar to that of diabetes, but somewhat higher for the African and Western Pacific Regions, and slightly lower in the North America and Caribbean Region.




Map 2.3 Prevalence* (%) estimates of impaired glucose tolerance (20-79 years), 2010

http://www.diabetesatlas.org/content/impaired-glucose-tolerance

.